Please login to the form below

Not currently logged in
Email:
Password:

inVentiv adds Joanne Wunder to leadership team

Joins PR unit Biosector 2
Jo-Wunder inventiv

The life science services company inVentiv Health has named Joanne Wunder as European client development lead at its Biosector 2 unit.

Wunder brings more than 20 years of experience in healthcare communications to Biosector 2, which is focused on healthcare PR.

Michel Dubery, European commercial managing director, inVentiv Health, said: “With Joanne as part of our European leadership, we believe we are not only strengthening our role as partners to our clients, but also as leaders in effective healthcare communications.”

Wunder was most recently business unit head at Ogilvy HealthPR. She previously held senior positions in medical education and journalism.

On her appointment Wunder said: “Through our network and shared expertise we can quickly assemble the cross-disciplinary expertise, services and team needed to deliver successful solutions for our clients, when and how they need it most.”

13th November 2014

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Founded in 2015, Windrose Consulting Group is a privately-held global strategy firm that partners with life science companies to maximize...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...